• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碳环类塞美拉诺肽类似物在黑皮质素4受体上保持生化活性。

Carbocyclic setmelanotide analogs maintain biochemical potency at melanocortin 4 receptors.

作者信息

Gary Samuel, Roy Anuradha, Bloom Steven

机构信息

Department of Medicinal Chemistry, University of Kansas, Lawrence, Kansas, USA.

High Throughput Screening Laboratory, University of Kansas, Lawrence, Kansas, USA.

出版信息

J Pept Sci. 2025 Feb;31(2):e3656. doi: 10.1002/psc.3656. Epub 2024 Oct 12.

DOI:10.1002/psc.3656
PMID:39394922
Abstract

The melanocortin 4 receptor (MC4R) plays a critical role in satiety and energy homeostasis, and its dysregulation is implicated in numerous hyperphagic and obese disease states. Setmelanotide, a disulfide-based cyclic peptide, can rescue MC4R activity and treat obesities caused by genetic defects in MC4R signaling. But this peptide has moderate blood-brain barrier penetrance and metabolic stability, which can limit its efficacy in practice. Based on the cryo-electron microscopy structure of setmelanotide-bound MC4R, we hypothesized that replacing its lone disulfide bond with more metabolically stable and permeability-enhancing carbon-based linker groups could improve pharmacokinetic properties without abolishing activity. To test this, we used chemistry developed by our lab to prepare 11 carbocyclic (alkyl, aryl, perfluoroalkyl, and ethereal) analogs of setmelanotide and determined their biochemical potencies at MC4R in vitro. Ten analogs displayed full agonism, showing that disulfide replacement is tolerant of linkers ranging in size, rigidity, and functional groups, with heteroatom- or aryl-rich linkers displaying superior potencies.

摘要

黑皮质素4受体(MC4R)在饱腹感和能量稳态中起关键作用,其功能失调与多种食欲亢进和肥胖疾病状态有关。Setmelanotide是一种基于二硫键的环肽,可恢复MC4R活性并治疗由MC4R信号通路遗传缺陷引起的肥胖症。但这种肽具有中等的血脑屏障穿透性和代谢稳定性,这可能会限制其在实际应用中的疗效。基于与Setmelanotide结合的MC4R的冷冻电子显微镜结构,我们推测用代谢更稳定且能增强通透性的碳基连接基团取代其唯一的二硫键,可以改善药代动力学性质而不消除活性。为了验证这一点,我们利用实验室开发的化学方法制备了11种Setmelanotide的碳环(烷基、芳基、全氟烷基和醚类)类似物,并在体外测定了它们对MC4R的生化活性。十种类似物表现出完全激动作用,表明二硫键取代对大小、刚性和官能团各异的连接基团具有耐受性,富含杂原子或芳基的连接基团表现出更高的活性。

相似文献

1
Carbocyclic setmelanotide analogs maintain biochemical potency at melanocortin 4 receptors.碳环类塞美拉诺肽类似物在黑皮质素4受体上保持生化活性。
J Pept Sci. 2025 Feb;31(2):e3656. doi: 10.1002/psc.3656. Epub 2024 Oct 12.
2
Investigation of setmelanotide, an MC4R agonist, for obesity in individuals with Smith-Magenis syndrome.研究 MC4R 激动剂 setmelanotide 治疗 Smith-Magenis 综合征患者肥胖的效果。
Obes Res Clin Pract. 2024 Jul-Aug;18(4):301-307. doi: 10.1016/j.orcp.2024.07.001. Epub 2024 Jul 10.
3
The melanocortin-4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic options.黑皮质素-4 受体作为肥胖治疗靶点:新兴药理学治疗选择的系统评价。
Int J Obes (Lond). 2014 Feb;38(2):163-9. doi: 10.1038/ijo.2013.80. Epub 2013 Jun 18.
4
Structural analysis of setmelanotide binding to MC4R variants in comparison to wild-type receptor.SET 结构域分析与 MC4R 野生型受体相比,突变型 MC4R 对黑素细胞刺激素的结合。
Life Sci. 2022 Oct 15;307:120857. doi: 10.1016/j.lfs.2022.120857. Epub 2022 Aug 2.
5
Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency.MC4R 缺乏症中黑皮质素-4 受体(MC4R)激动剂(Setmelanotide)的评估。
Mol Metab. 2017 Oct;6(10):1321-1329. doi: 10.1016/j.molmet.2017.06.015. Epub 2017 Jul 8.
6
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
7
Ovarian hormones and obesity.卵巢激素与肥胖
Hum Reprod Update. 2017 May 1;23(3):300-321. doi: 10.1093/humupd/dmw045.
8
MC4R Variants Modulate α-MSH and Setmelanotide Induced Cellular Signaling at Multiple Levels.MC4R变异体在多个水平调节α-MSH和setmelanotide诱导的细胞信号传导。
J Clin Endocrinol Metab. 2024 Sep 16;109(10):2452-2466. doi: 10.1210/clinem/dgae210.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.